Eckner R, Ewen ME, Newsome D, Gerdes M, DeCaprio JA, Lawrence JB, Livingston DM (1994. április 1.). „Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor”. Genes Dev.8 (8), 869–84. o. DOI:10.1101/gad.8.8.869. PMID7523245.
Ogryzko VV, Schiltz RL, Russanova V, Howard BH, Nakatani Y (1996). „The transcriptional coactivators p300 and CBP are histone acetyltransferases”. Cell87 (5), 953–9. o. DOI:10.1016/S0092-8674(00)82001-2. PMID8945521.
Ntranos A, Casaccia P (2016. június 1.). „Bromodomains: Translating the words of lysine acetylation into myelin injury and repair”. Neuroscience Letters625, 4–10. o. DOI:10.1016/j.neulet.2015.10.015. PMID26472704. PMC4841751.
Teufel DP, Freund SM, Bycroft M, Fersht AR (2007. április 1.). „Four domains of p300 each bind tightly to a sequence spanning both transactivation subdomains of p53”. PNAS104 (17), 7009–7014. o. DOI:10.1073/pnas.0702010104. PMID17438265. PMC1855428.; Piskacek S, Gregor M, Nemethova M, Grabner M, Kovarik P, Piskacek M (2007. június 1.). „Nine-amino-acid transactivation domain: establishment and prediction utilities”. Genomics89 (6), 756–68. o. DOI:10.1016/j.ygeno.2007.02.003. PMID17467953.
Roelfsema JH, White SJ, Ariyürek Y, Bartholdi D, Niedrist D, Papadia F, Bacino CA, den Dunnen JT, van Ommen G-JB, Breuning MH, Hennekam RC, Peters DJM (2005. február 10.). „Genetic Heterogeneity in Rubinstein-Taybi Syndrome: Mutations in Both the CBP and EP300 Genes Cause Disease”. Am J Hum Genet76 (4), 572–580. o. DOI:10.1086/429130. PMID15706485. PMC1199295. (Hozzáférés: 2023. december 13.)
Liguori G, Cantile M, Collina F, Marra L, de Chiara A, Franco R, Caraglia M, Botti G, D'Andrea M, Nicoletti GF (2015. április 27.). „Atypical amplification of chromosome region 22q12 in melanoma: A case report”. DOI:10.1242/dmm.049078. PMID26171028. PMC4487132. (Hozzáférés: 2023. december 13.)
Bordonaro M, Lazarova DL (2015. július 21.). „CREB-binding protein, p300, butyrate, and Wnt signaling in colorectal cancer”. World J Gastroenterol21 (27), 8238–8248. o. DOI:10.3748/wjg.v21.i27.8238. PMID26217075. PMC4507093.
Zeng Q, Wang K, Zhao Y, Ma Q, Chen Z, Huang W (2023. február 22.). „Effects of the Acetyltransferase p300 on Tumour Regulation from the Novel Perspective of Posttranslational Protein Modification”. Biomolecules23 (24), 4225–4231. o. DOI:10.3390/biom13030417. PMID36979352. PMC10046601.
Zhong Z, Harmston N, Wood KC, Madan B, Virshup DM (2022. június 15.). „A p300/GATA6 axis determines differentiation and Wnt dependency in pancreatic cancer models”. J Clin Invest132 (12), e156305. o. DOI:10.1038/sj.onc.1207118. PMID15156177.
Zhong J, Ding L, Bohrer LR, Pan Y, Liu P, Zhang J, Sebo TJ, Karnes RJ, Tindall DJ, van Deursen J, Huang H (2014. január 30.). „P300 acetyltransferase regulates androgen receptor degradation and PTEN-deficient prostate tumorigenesis”. Cancer Res74 (6), 1870–1880. o. DOI:10.1158/0008-5472.CAN-13-2485. PMID24480624. PMC3971883.
Na SY, Choi JE, Kim HJ, Jhun BH, Lee YC, Lee JW (1999. október 1.). „Bcl3, an IkappaB protein, stimulates activating protein-1 transactivation and cellular proliferation”. J. Biol. Chem.274 (40), 28491–6. o. DOI:10.1074/jbc.274.40.28491. PMID10497212.
Pao GM, Janknecht R, Ruffner H, Hunter T, Verma IM (2000. február 1.). „CBP/p300 interact with and function as transcriptional coactivators of BRCA1”. Proc. Natl. Acad. Sci. U.S.A.97 (3), 1020–5. o. DOI:10.1073/pnas.97.3.1020. PMID10655477. PMC15508.
Hussain MA, Habener JF (1999. október 1.). „Glucagon gene transcription activation mediated by synergistic interactions of pax-6 and cdx-2 with the p300 co-activator”. J. Biol. Chem.274 (41), 28950–7. o. DOI:10.1074/jbc.274.41.28950. PMID10506141.
Yahata T, de Caestecker MP, Lechleider RJ, Andriole S, Roberts AB, Isselbacher KJ, Shioda T (2000. március 1.). „The MSG1 non-DNA-binding transactivator binds to the p300/CBP coactivators, enhancing their functional link to the Smad transcription factors”. J. Biol. Chem.275 (12), 8825–34. o. DOI:10.1074/jbc.275.12.8825. PMID10722728.
Bhattacharya S, Michels CL, Leung MK, Arany ZP, Kung AL, Livingston DM (1999. január 1.). „Functional role of p35srj, a novel p300/CBP binding protein, during transactivation by HIF-1”. Genes Dev.13 (1), 64–75. o. DOI:10.1101/gad.13.1.64. PMID9887100. PMC316375.
Bragança J, Eloranta JJ, Bamforth SD, Ibbitt JC, Hurst HC, Bhattacharya S (2003. május 1.). „Physical and functional interactions among AP-2 transcription factors, p300/CREB-binding protein, and CITED2”. J. Biol. Chem.278 (18), 16021–9. o. DOI:10.1074/jbc.M208144200. PMID12586840.
Bragança J, Swingler T, Marques FI, Jones T, Eloranta JJ, Hurst HC, Shioda T, Bhattacharya S (2002. március 1.). „Human CREB-binding protein/p300-interacting transactivator with ED-rich tail (CITED) 4, a new member of the CITED family, functions as a co-activator for transcription factor AP-2”. J. Biol. Chem.277 (10), 8559–65. o. DOI:10.1074/jbc.M110850200. PMID11744733.
Glenn DJ, Maurer RA (1999. december 1.). „MRG1 binds to the LIM domain of Lhx2 and may function as a coactivator to stimulate glycoprotein hormone alpha-subunit gene expression”. J. Biol. Chem.274 (51), 36159–67. o. DOI:10.1074/jbc.274.51.36159. PMID10593900.
Rossow KL, Janknecht R (2003. január 1.). „Synergism between p68 RNA helicase and the transcriptional coactivators CBP and p300”. Oncogene22 (1), 151–6. o. DOI:10.1038/sj.onc.1206067. PMID12527917.
Yamamoto N, Yamamoto S, Inagaki F, Kawaichi M, Fukamizu A, Kishi N, Matsuno K, Nakamura K, Weinmaster G, Okano H, Nakafuku M (2001. november 1.). „Role of Deltex-1 as a transcriptional regulator downstream of the Notch receptor”. J. Biol. Chem.276 (48), 45031–40. o. DOI:10.1074/jbc.M105245200. PMID11564735.
Li QJ, Yang SH, Maeda Y, Sladek FM, Sharrocks AD, Martins-Green M (2003. január 1.). „MAP kinase phosphorylation-dependent activation of Elk-1 leads to activation of the co-activator p300”. EMBO J.22 (2), 281–91. o. DOI:10.1093/emboj/cdg028. PMID12514134. PMC140103.
Fajas L, Egler V, Reiter R, Hansen J, Kristiansen K, Debril MB, Miard S, Auwerx J (2002. december 1.). „The retinoblastoma-histone deacetylase 3 complex inhibits PPARgamma and adipocyte differentiation”. Dev. Cell3 (6), 903–10. o. DOI:10.1016/s1534-5807(02)00360-x. PMID12479814.
Kang YK, Guermah M, Yuan CX, Roeder RG (2002. március 1.). „The TRAP/Mediator coactivator complex interacts directly with estrogen receptors alpha and beta through the TRAP220 subunit and directly enhances estrogen receptor function in vitro”. Proc. Natl. Acad. Sci. U.S.A.99 (5), 2642–7. o. DOI:10.1073/pnas.261715899. PMID11867769. PMC122401.
Hasan S, Stucki M, Hassa PO, Imhof R, Gehrig P, Hunziker P, Hübscher U, Hottiger MO (2001. június 1.). „Regulation of human flap endonuclease-1 activity by acetylation through the transcriptional coactivator p300”. Mol. Cell7 (6), 1221–31. o. DOI:10.1016/s1097-2765(01)00272-6. PMID11430825.
Lando D, Peet DJ, Whelan DA, Gorman JJ, Whitelaw ML (2002. február 1.). „Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch”. Science295 (5556), 858–61. o. DOI:10.1126/science.1068592. PMID11823643.
Freedman SJ, Sun ZY, Poy F, Kung AL, Livingston DM, Wagner G, Eck MJ (2002. április 1.). „Structural basis for recruitment of CBP/p300 by hypoxia-inducible factor-1 alpha”. Proc. Natl. Acad. Sci. U.S.A.99 (8), 5367–72. o. DOI:10.1073/pnas.082117899. PMID11959990. PMC122775.
Masumi A, Ozato K (2001. június 1.). „Coactivator p300 acetylates the interferon regulatory factor-2 in U937 cells following phorbol ester treatment”. J. Biol. Chem.276 (24), 20973–80. o. DOI:10.1074/jbc.M101707200. PMID11304541.
Hecht A, Stemmler MP (2003. február 1.). „Identification of a promoter-specific transcriptional activation domain at the C terminus of the Wnt effector protein T-cell factor 4”. J. Biol. Chem.278 (6), 3776–85. o. DOI:10.1074/jbc.M210081200. PMID12446687.
Chen Q, Dowhan DH, Liang D, Moore DD, Overbeek PA (2002. július 1.). „CREB-binding protein/p300 co-activation of crystallin gene expression”. J. Biol. Chem.277 (27), 24081–9. o. DOI:10.1074/jbc.M201821200. PMID11943779.
Fryer CJ, Lamar E, Turbachova I, Kintner C, Jones KA (2002. június 1.). „Mastermind mediates chromatin-specific transcription and turnover of the Notch enhancer complex”. Genes Dev.16 (11), 1397–411. o. DOI:10.1101/gad.991602. PMID12050117. PMC186317.
Youn HD, Grozinger CM, Liu JO (2000. július 1.). „Calcium regulates transcriptional repression of myocyte enhancer factor 2 by histone deacetylase 4”. J. Biol. Chem.275 (29), 22563–7. o. DOI:10.1074/jbc.C000304200. PMID10825153.
Youn HD, Liu JO (2000. július 1.). „Cabin1 represses MEF2-dependent Nur77 expression and T cell apoptosis by controlling association of histone deacetylases and acetylases with MEF2”. Immunity13 (1), 85–94. o. DOI:10.1016/s1074-7613(00)00010-8. PMID10933397.
Johnson LR, Johnson TK, Desler M, Luster TA, Nowling T, Lewis RE, Rizzino A (2002. február 1.). „Effects of B-Myb on gene transcription: phosphorylation-dependent activity and acetylation by p300”. J. Biol. Chem.277 (6), 4088–97. o. DOI:10.1074/jbc.M105112200. PMID11733503.
Grossman SR, Perez M, Kung AL, Joseph M, Mansur C, Xiao ZX, Kumar S, Howley PM, Livingston DM (1998. október 1.). „p300/MDM2 complexes participate in MDM2-mediated p53 degradation”. Mol. Cell2 (4), 405–15. o. DOI:10.1016/s1097-2765(00)80140-9. PMID9809062.
Lau P, Bailey P, Dowhan DH, Muscat GE (1999. január 1.). „Exogenous expression of a dominant negative RORalpha1 vector in muscle cells impairs differentiation: RORalpha1 directly interacts with p300 and myoD”. Nucleic Acids Res.27 (2), 411–20. o. DOI:10.1093/nar/27.2.411. PMID9862959. PMC148194.
De Luca A, Severino A, De Paolis P, Cottone G, De Luca L, De Falco M, Porcellini A, Volpe M, Condorelli G (2003. február 1.). „p300/cAMP-response-element-binding-protein ('CREB')-binding protein (CBP) modulates co-operation between myocyte enhancer factor 2A (MEF2A) and thyroid hormone receptor-retinoid X receptor”. Biochem. J.369 (Pt 3), 477–84. o. DOI:10.1042/BJ20020057. PMID12371907. PMC1223100.
Ko L, Cardona GR, Chin WW (2000. május 1.). „Thyroid hormone receptor-binding protein, an LXXLL motif-containing protein, functions as a general coactivator”. Proc. Natl. Acad. Sci. U.S.A.97 (11), 6212–7. o. DOI:10.1073/pnas.97.11.6212. PMID10823961. PMC18584.
García-Rodríguez C, Rao A (1998. június 1.). „Nuclear factor of activated T cells (NFAT)-dependent transactivation regulated by the coactivators p300/CREB-binding protein (CBP)”. J. Exp. Med.187 (12), 2031–6. o. DOI:10.1084/jem.187.12.2031. PMID9625762. PMC2212364.
Curtis AM, Seo SB, Westgate EJ, Rudic RD, Smyth EM, Chakravarti D, FitzGerald GA, McNamara P (2004. február 1.). „Histone acetyltransferase-dependent chromatin remodeling and the vascular clock”. J. Biol. Chem.279 (8), 7091–7. o. DOI:10.1074/jbc.M311973200. PMID14645221.
Avantaggiati ML, Ogryzko V, Gardner K, Giordano A, Levine AS, Kelly K (1997). „Recruitment of p300/CBP in p53-dependent signal pathways”. Cell89 (7), 1175–84. o. DOI:10.1016/s0092-8674(00)80304-9. PMID9215639.
An W, Kim J, Roeder RG (2004. június 1.). „Ordered cooperative functions of PRMT1, p300, and CARM1 in transcriptional activation by p53”. Cell117 (6), 735–48. o. DOI:10.1016/j.cell.2004.05.009. PMID15186775.
Pastorcic M, Das HK (2000. november 1.). „Regulation of transcription of the human presenilin-1 gene by ets transcription factors and the p53 protooncogene”. J. Biol. Chem.275 (45), 34938–45. o. DOI:10.1074/jbc.M005411200. PMID10942770.
Livengood JA, Scoggin KE, Van Orden K, McBryant SJ, Edayathumangalam RS, Laybourn PJ, Nyborg JK (2002. március 1.). „p53 Transcriptional activity is mediated through the SRC1-interacting domain of CBP/p300”. J. Biol. Chem.277 (11), 9054–61. o. DOI:10.1074/jbc.M108870200. PMID11782467.
Hasan S, Hassa PO, Imhof R, Hottiger MO (2001. március 1.). „Transcription coactivator p300 binds PCNA and may have a role in DNA repair synthesis”. Nature410 (6826), 387–91. o. DOI:10.1038/35066610. PMID11268218.
Dowell P, Ishmael JE, Avram D, Peterson VJ, Nevrivy DJ, Leid M (1997. december 1.). „p300 functions as a coactivator for the peroxisome proliferator-activated receptor alpha”. J. Biol. Chem.272 (52), 33435–43. o. DOI:10.1074/jbc.272.52.33435. PMID9407140.
Dowell P, Ishmael JE, Avram D, Peterson VJ, Nevrivy DJ, Leid M (1999. május 1.). „Identification of nuclear receptor corepressor as a peroxisome proliferator-activated receptor alpha interacting protein”. J. Biol. Chem.274 (22), 15901–7. o. DOI:10.1074/jbc.274.22.15901. PMID10336495.
Kodera Y, Takeyama K, Murayama A, Suzawa M, Masuhiro Y, Kato S (2000. október 1.). „Ligand type-specific interactions of peroxisome proliferator-activated receptor gamma with transcriptional coactivators”. J. Biol. Chem.275 (43), 33201–4. o. DOI:10.1074/jbc.C000517200. PMID10944516.
Kiernan R, Brès V, Ng RW, Coudart MP, El Messaoudi S, Sardet C, Jin DY, Emiliani S, Benkirane M (2003. január 1.). „Post-activation turn-off of NF-kappa B-dependent transcription is regulated by acetylation of p65”. J. Biol. Chem.278 (4), 2758–66. o. DOI:10.1074/jbc.M209572200. PMID12419806.
Gerritsen ME, Williams AJ, Neish AS, Moore S, Shi Y, Collins T (1997. április 1.). „CREB-binding protein/p300 are transcriptional coactivators of p65”. Proc. Natl. Acad. Sci. U.S.A.94 (7), 2927–32. o. DOI:10.1073/pnas.94.7.2927. PMID9096323. PMC20299.
Pearson KL, Hunter T, Janknecht R (1999. december 1.). „Activation of Smad1-mediated transcription by p300/CBP”. Biochim. Biophys. Acta1489 (2–3), 354–64. o. DOI:10.1016/S0167-4781(99)00166-9. PMID10673036.
Nakashima K, Yanagisawa M, Arakawa H, Kimura N, Hisatsune T, Kawabata M, Miyazono K, Taga T (1999. április 1.). „Synergistic signaling in fetal brain by STAT3-Smad1 complex bridged by p300”. Science284 (5413), 479–82. o. DOI:10.1126/science.284.5413.479. PMID10205054.
Pessah M, Prunier C, Marais J, Ferrand N, Mazars A, Lallemand F, Gauthier JM, Atfi A (2001. május 1.). „c-Jun interacts with the corepressor TG-interacting factor (TGIF) to suppress Smad2 transcriptional activity”. Proc. Natl. Acad. Sci. U.S.A.98 (11), 6198–203. o. DOI:10.1073/pnas.101579798. PMID11371641. PMC33445.
Grönroos E, Hellman U, Heldin CH, Ericsson J (2002. szeptember 1.). „Control of Smad7 stability by competition between acetylation and ubiquitination”. Mol. Cell10 (3), 483–93. o. DOI:10.1016/s1097-2765(02)00639-1. PMID12408818.
Kim RH, Wang D, Tsang M, Martin J, Huff C, de Caestecker MP, Parks WT, Meng X, Lechleider RJ, Wang T, Roberts AB (2000. július 1.). „A novel smad nuclear interacting protein, SNIP1, suppresses p300-dependent TGF-beta signal transduction”. Genes Dev.14 (13), 1605–16. o. DOI:10.1101/gad.14.13.1605. PMID10887155. PMC316742.
Eid JE, Kung AL, Scully R, Livingston DM (2000. szeptember 1.). „p300 interacts with the nuclear proto-oncoprotein SYT as part of the active control of cell adhesion”. Cell102 (6), 839–48. o. DOI:10.1016/s0092-8674(00)00072-6. PMID11030627.
McDonald C, Reich NC (1999. július 1.). „Cooperation of the transcriptional coactivators CBP and p300 with Stat6”. J. Interferon Cytokine Res.19 (7), 711–22. o. DOI:10.1089/107999099313550. PMID10454341.
Huang S, Qiu Y, Stein RW, Brandt SJ (1999. szeptember 1.). „p300 functions as a transcriptional coactivator for the TAL1/SCL oncoprotein”. Oncogene18 (35), 4958–67. o. DOI:10.1038/sj.onc.1202889. PMID10490830.
Bradney C, Hjelmeland M, Komatsu Y, Yoshida M, Yao TP, Zhuang Y (2003. január 1.). „Regulation of E2A activities by histone acetyltransferases in B lymphocyte development”. J. Biol. Chem.278 (4), 2370–6. o. DOI:10.1074/jbc.M211464200. PMID12435739.
Misra P, Qi C, Yu S, Shah SH, Cao WQ, Rao MS, Thimmapaya B, Zhu Y, Reddy JK (2002. május 1.). „Interaction of PIMT with transcriptional coactivators CBP, p300, and PBP differential role in transcriptional regulation”. J. Biol. Chem.277 (22), 20011–9. o. DOI:10.1074/jbc.M201739200. PMID11912212.
Gizard F, Lavallée B, DeWitte F, Hum DW (2001. szeptember 1.). „A novel zinc finger protein TReP-132 interacts with CBP/p300 to regulate human CYP11A1 gene expression”. J. Biol. Chem.276 (36), 33881–92. o. DOI:10.1074/jbc.M100113200. PMID11349124.
Hamamori Y, Sartorelli V, Ogryzko V, Puri PL, Wu HY, Wang JY, Nakatani Y, Kedes L (1999. február 1.). „Regulation of histone acetyltransferases p300 and PCAF by the bHLH protein twist and adenoviral oncoprotein E1A”. Cell96 (3), 405–13. o. DOI:10.1016/S0092-8674(00)80553-X. PMID10025406.
Lee JS, Galvin KM, See RH, Eckner R, Livingston D, Moran E, Shi Y (1995. május 1.). „Relief of YY1 transcriptional repression by adenovirus E1A is mediated by E1A-associated protein p300”. Genes Dev.9 (10), 1188–98. o. DOI:10.1101/gad.9.10.1188. PMID7758944.
Silverman ES, Du J, Williams AJ, Wadgaonkar R, Drazen JM, Collins T (1998. november 1.). „cAMP-response-element-binding-protein-binding protein (CBP) and p300 are transcriptional co-activators of early growth response factor-1 (Egr-1)”. Biochem. J.336 (1), 183–9. o. DOI:10.1042/bj3360183. PMID9806899. PMC1219856.
nih.gov
pubmed.ncbi.nlm.nih.gov
Eckner R, Ewen ME, Newsome D, Gerdes M, DeCaprio JA, Lawrence JB, Livingston DM (1994. április 1.). „Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor”. Genes Dev.8 (8), 869–84. o. DOI:10.1101/gad.8.8.869. PMID7523245.
Ogryzko VV, Schiltz RL, Russanova V, Howard BH, Nakatani Y (1996). „The transcriptional coactivators p300 and CBP are histone acetyltransferases”. Cell87 (5), 953–9. o. DOI:10.1016/S0092-8674(00)82001-2. PMID8945521.
Ntranos A, Casaccia P (2016. június 1.). „Bromodomains: Translating the words of lysine acetylation into myelin injury and repair”. Neuroscience Letters625, 4–10. o. DOI:10.1016/j.neulet.2015.10.015. PMID26472704. PMC4841751.
Teufel DP, Freund SM, Bycroft M, Fersht AR (2007. április 1.). „Four domains of p300 each bind tightly to a sequence spanning both transactivation subdomains of p53”. PNAS104 (17), 7009–7014. o. DOI:10.1073/pnas.0702010104. PMID17438265. PMC1855428.; Piskacek S, Gregor M, Nemethova M, Grabner M, Kovarik P, Piskacek M (2007. június 1.). „Nine-amino-acid transactivation domain: establishment and prediction utilities”. Genomics89 (6), 756–68. o. DOI:10.1016/j.ygeno.2007.02.003. PMID17467953.
Roelfsema JH, White SJ, Ariyürek Y, Bartholdi D, Niedrist D, Papadia F, Bacino CA, den Dunnen JT, van Ommen G-JB, Breuning MH, Hennekam RC, Peters DJM (2005. február 10.). „Genetic Heterogeneity in Rubinstein-Taybi Syndrome: Mutations in Both the CBP and EP300 Genes Cause Disease”. Am J Hum Genet76 (4), 572–580. o. DOI:10.1086/429130. PMID15706485. PMC1199295. (Hozzáférés: 2023. december 13.)
Liguori G, Cantile M, Collina F, Marra L, de Chiara A, Franco R, Caraglia M, Botti G, D'Andrea M, Nicoletti GF (2015. április 27.). „Atypical amplification of chromosome region 22q12 in melanoma: A case report”. DOI:10.1242/dmm.049078. PMID26171028. PMC4487132. (Hozzáférés: 2023. december 13.)
Bordonaro M, Lazarova DL (2015. július 21.). „CREB-binding protein, p300, butyrate, and Wnt signaling in colorectal cancer”. World J Gastroenterol21 (27), 8238–8248. o. DOI:10.3748/wjg.v21.i27.8238. PMID26217075. PMC4507093.
Zeng Q, Wang K, Zhao Y, Ma Q, Chen Z, Huang W (2023. február 22.). „Effects of the Acetyltransferase p300 on Tumour Regulation from the Novel Perspective of Posttranslational Protein Modification”. Biomolecules23 (24), 4225–4231. o. DOI:10.3390/biom13030417. PMID36979352. PMC10046601.
Zhong Z, Harmston N, Wood KC, Madan B, Virshup DM (2022. június 15.). „A p300/GATA6 axis determines differentiation and Wnt dependency in pancreatic cancer models”. J Clin Invest132 (12), e156305. o. DOI:10.1038/sj.onc.1207118. PMID15156177.
Zhong J, Ding L, Bohrer LR, Pan Y, Liu P, Zhang J, Sebo TJ, Karnes RJ, Tindall DJ, van Deursen J, Huang H (2014. január 30.). „P300 acetyltransferase regulates androgen receptor degradation and PTEN-deficient prostate tumorigenesis”. Cancer Res74 (6), 1870–1880. o. DOI:10.1158/0008-5472.CAN-13-2485. PMID24480624. PMC3971883.
Na SY, Choi JE, Kim HJ, Jhun BH, Lee YC, Lee JW (1999. október 1.). „Bcl3, an IkappaB protein, stimulates activating protein-1 transactivation and cellular proliferation”. J. Biol. Chem.274 (40), 28491–6. o. DOI:10.1074/jbc.274.40.28491. PMID10497212.
Fan S, Ma YX, Wang C, Yuan RQ, Meng Q, Wang JA, Erdos M, Goldberg ID, Webb P, Kushner PJ, Pestell RG, Rosen EM (2002. január 1.). „p300 Modulates the BRCA1 inhibition of estrogen receptor activity”. Cancer Res.62 (1), 141–51. o. PMID11782371.
Pao GM, Janknecht R, Ruffner H, Hunter T, Verma IM (2000. február 1.). „CBP/p300 interact with and function as transcriptional coactivators of BRCA1”. Proc. Natl. Acad. Sci. U.S.A.97 (3), 1020–5. o. DOI:10.1073/pnas.97.3.1020. PMID10655477. PMC15508.
Hussain MA, Habener JF (1999. október 1.). „Glucagon gene transcription activation mediated by synergistic interactions of pax-6 and cdx-2 with the p300 co-activator”. J. Biol. Chem.274 (41), 28950–7. o. DOI:10.1074/jbc.274.41.28950. PMID10506141.
Yahata T, de Caestecker MP, Lechleider RJ, Andriole S, Roberts AB, Isselbacher KJ, Shioda T (2000. március 1.). „The MSG1 non-DNA-binding transactivator binds to the p300/CBP coactivators, enhancing their functional link to the Smad transcription factors”. J. Biol. Chem.275 (12), 8825–34. o. DOI:10.1074/jbc.275.12.8825. PMID10722728.
Bhattacharya S, Michels CL, Leung MK, Arany ZP, Kung AL, Livingston DM (1999. január 1.). „Functional role of p35srj, a novel p300/CBP binding protein, during transactivation by HIF-1”. Genes Dev.13 (1), 64–75. o. DOI:10.1101/gad.13.1.64. PMID9887100. PMC316375.
Bragança J, Eloranta JJ, Bamforth SD, Ibbitt JC, Hurst HC, Bhattacharya S (2003. május 1.). „Physical and functional interactions among AP-2 transcription factors, p300/CREB-binding protein, and CITED2”. J. Biol. Chem.278 (18), 16021–9. o. DOI:10.1074/jbc.M208144200. PMID12586840.
Bragança J, Swingler T, Marques FI, Jones T, Eloranta JJ, Hurst HC, Shioda T, Bhattacharya S (2002. március 1.). „Human CREB-binding protein/p300-interacting transactivator with ED-rich tail (CITED) 4, a new member of the CITED family, functions as a co-activator for transcription factor AP-2”. J. Biol. Chem.277 (10), 8559–65. o. DOI:10.1074/jbc.M110850200. PMID11744733.
Glenn DJ, Maurer RA (1999. december 1.). „MRG1 binds to the LIM domain of Lhx2 and may function as a coactivator to stimulate glycoprotein hormone alpha-subunit gene expression”. J. Biol. Chem.274 (51), 36159–67. o. DOI:10.1074/jbc.274.51.36159. PMID10593900.
Rossow KL, Janknecht R (2003. január 1.). „Synergism between p68 RNA helicase and the transcriptional coactivators CBP and p300”. Oncogene22 (1), 151–6. o. DOI:10.1038/sj.onc.1206067. PMID12527917.
Yamamoto N, Yamamoto S, Inagaki F, Kawaichi M, Fukamizu A, Kishi N, Matsuno K, Nakamura K, Weinmaster G, Okano H, Nakafuku M (2001. november 1.). „Role of Deltex-1 as a transcriptional regulator downstream of the Notch receptor”. J. Biol. Chem.276 (48), 45031–40. o. DOI:10.1074/jbc.M105245200. PMID11564735.
Li QJ, Yang SH, Maeda Y, Sladek FM, Sharrocks AD, Martins-Green M (2003. január 1.). „MAP kinase phosphorylation-dependent activation of Elk-1 leads to activation of the co-activator p300”. EMBO J.22 (2), 281–91. o. DOI:10.1093/emboj/cdg028. PMID12514134. PMC140103.
Fajas L, Egler V, Reiter R, Hansen J, Kristiansen K, Debril MB, Miard S, Auwerx J (2002. december 1.). „The retinoblastoma-histone deacetylase 3 complex inhibits PPARgamma and adipocyte differentiation”. Dev. Cell3 (6), 903–10. o. DOI:10.1016/s1534-5807(02)00360-x. PMID12479814.
Kang YK, Guermah M, Yuan CX, Roeder RG (2002. március 1.). „The TRAP/Mediator coactivator complex interacts directly with estrogen receptors alpha and beta through the TRAP220 subunit and directly enhances estrogen receptor function in vitro”. Proc. Natl. Acad. Sci. U.S.A.99 (5), 2642–7. o. DOI:10.1073/pnas.261715899. PMID11867769. PMC122401.
Hasan S, Stucki M, Hassa PO, Imhof R, Gehrig P, Hunziker P, Hübscher U, Hottiger MO (2001. június 1.). „Regulation of human flap endonuclease-1 activity by acetylation through the transcriptional coactivator p300”. Mol. Cell7 (6), 1221–31. o. DOI:10.1016/s1097-2765(01)00272-6. PMID11430825.
Lando D, Peet DJ, Whelan DA, Gorman JJ, Whitelaw ML (2002. február 1.). „Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch”. Science295 (5556), 858–61. o. DOI:10.1126/science.1068592. PMID11823643.
Freedman SJ, Sun ZY, Poy F, Kung AL, Livingston DM, Wagner G, Eck MJ (2002. április 1.). „Structural basis for recruitment of CBP/p300 by hypoxia-inducible factor-1 alpha”. Proc. Natl. Acad. Sci. U.S.A.99 (8), 5367–72. o. DOI:10.1073/pnas.082117899. PMID11959990. PMC122775.
Shiseki M, Nagashima M, Pedeux RM, Kitahama-Shiseki M, Miura K, Okamura S, Onogi H, Higashimoto Y, Appella E, Yokota J, Harris CC (2003. május 1.). „p29ING4 and p28ING5 bind to p53 and p300, and enhance p53 activity”. Cancer Res.63 (10), 2373–8. o. PMID12750254.
Masumi A, Ozato K (2001. június 1.). „Coactivator p300 acetylates the interferon regulatory factor-2 in U937 cells following phorbol ester treatment”. J. Biol. Chem.276 (24), 20973–80. o. DOI:10.1074/jbc.M101707200. PMID11304541.
Hecht A, Stemmler MP (2003. február 1.). „Identification of a promoter-specific transcriptional activation domain at the C terminus of the Wnt effector protein T-cell factor 4”. J. Biol. Chem.278 (6), 3776–85. o. DOI:10.1074/jbc.M210081200. PMID12446687.
Chen Q, Dowhan DH, Liang D, Moore DD, Overbeek PA (2002. július 1.). „CREB-binding protein/p300 co-activation of crystallin gene expression”. J. Biol. Chem.277 (27), 24081–9. o. DOI:10.1074/jbc.M201821200. PMID11943779.
Fryer CJ, Lamar E, Turbachova I, Kintner C, Jones KA (2002. június 1.). „Mastermind mediates chromatin-specific transcription and turnover of the Notch enhancer complex”. Genes Dev.16 (11), 1397–411. o. DOI:10.1101/gad.991602. PMID12050117. PMC186317.
Youn HD, Grozinger CM, Liu JO (2000. július 1.). „Calcium regulates transcriptional repression of myocyte enhancer factor 2 by histone deacetylase 4”. J. Biol. Chem.275 (29), 22563–7. o. DOI:10.1074/jbc.C000304200. PMID10825153.
Youn HD, Liu JO (2000. július 1.). „Cabin1 represses MEF2-dependent Nur77 expression and T cell apoptosis by controlling association of histone deacetylases and acetylases with MEF2”. Immunity13 (1), 85–94. o. DOI:10.1016/s1074-7613(00)00010-8. PMID10933397.
Johnson LR, Johnson TK, Desler M, Luster TA, Nowling T, Lewis RE, Rizzino A (2002. február 1.). „Effects of B-Myb on gene transcription: phosphorylation-dependent activity and acetylation by p300”. J. Biol. Chem.277 (6), 4088–97. o. DOI:10.1074/jbc.M105112200. PMID11733503.
Grossman SR, Perez M, Kung AL, Joseph M, Mansur C, Xiao ZX, Kumar S, Howley PM, Livingston DM (1998. október 1.). „p300/MDM2 complexes participate in MDM2-mediated p53 degradation”. Mol. Cell2 (4), 405–15. o. DOI:10.1016/s1097-2765(00)80140-9. PMID9809062.
Lau P, Bailey P, Dowhan DH, Muscat GE (1999. január 1.). „Exogenous expression of a dominant negative RORalpha1 vector in muscle cells impairs differentiation: RORalpha1 directly interacts with p300 and myoD”. Nucleic Acids Res.27 (2), 411–20. o. DOI:10.1093/nar/27.2.411. PMID9862959. PMC148194.
De Luca A, Severino A, De Paolis P, Cottone G, De Luca L, De Falco M, Porcellini A, Volpe M, Condorelli G (2003. február 1.). „p300/cAMP-response-element-binding-protein ('CREB')-binding protein (CBP) modulates co-operation between myocyte enhancer factor 2A (MEF2A) and thyroid hormone receptor-retinoid X receptor”. Biochem. J.369 (Pt 3), 477–84. o. DOI:10.1042/BJ20020057. PMID12371907. PMC1223100.
Ko L, Cardona GR, Chin WW (2000. május 1.). „Thyroid hormone receptor-binding protein, an LXXLL motif-containing protein, functions as a general coactivator”. Proc. Natl. Acad. Sci. U.S.A.97 (11), 6212–7. o. DOI:10.1073/pnas.97.11.6212. PMID10823961. PMC18584.
García-Rodríguez C, Rao A (1998. június 1.). „Nuclear factor of activated T cells (NFAT)-dependent transactivation regulated by the coactivators p300/CREB-binding protein (CBP)”. J. Exp. Med.187 (12), 2031–6. o. DOI:10.1084/jem.187.12.2031. PMID9625762. PMC2212364.
Curtis AM, Seo SB, Westgate EJ, Rudic RD, Smyth EM, Chakravarti D, FitzGerald GA, McNamara P (2004. február 1.). „Histone acetyltransferase-dependent chromatin remodeling and the vascular clock”. J. Biol. Chem.279 (8), 7091–7. o. DOI:10.1074/jbc.M311973200. PMID14645221.
Avantaggiati ML, Ogryzko V, Gardner K, Giordano A, Levine AS, Kelly K (1997). „Recruitment of p300/CBP in p53-dependent signal pathways”. Cell89 (7), 1175–84. o. DOI:10.1016/s0092-8674(00)80304-9. PMID9215639.
An W, Kim J, Roeder RG (2004. június 1.). „Ordered cooperative functions of PRMT1, p300, and CARM1 in transcriptional activation by p53”. Cell117 (6), 735–48. o. DOI:10.1016/j.cell.2004.05.009. PMID15186775.
Pastorcic M, Das HK (2000. november 1.). „Regulation of transcription of the human presenilin-1 gene by ets transcription factors and the p53 protooncogene”. J. Biol. Chem.275 (45), 34938–45. o. DOI:10.1074/jbc.M005411200. PMID10942770.
Livengood JA, Scoggin KE, Van Orden K, McBryant SJ, Edayathumangalam RS, Laybourn PJ, Nyborg JK (2002. március 1.). „p53 Transcriptional activity is mediated through the SRC1-interacting domain of CBP/p300”. J. Biol. Chem.277 (11), 9054–61. o. DOI:10.1074/jbc.M108870200. PMID11782467.
Hasan S, Hassa PO, Imhof R, Hottiger MO (2001. március 1.). „Transcription coactivator p300 binds PCNA and may have a role in DNA repair synthesis”. Nature410 (6826), 387–91. o. DOI:10.1038/35066610. PMID11268218.
Dowell P, Ishmael JE, Avram D, Peterson VJ, Nevrivy DJ, Leid M (1997. december 1.). „p300 functions as a coactivator for the peroxisome proliferator-activated receptor alpha”. J. Biol. Chem.272 (52), 33435–43. o. DOI:10.1074/jbc.272.52.33435. PMID9407140.
Dowell P, Ishmael JE, Avram D, Peterson VJ, Nevrivy DJ, Leid M (1999. május 1.). „Identification of nuclear receptor corepressor as a peroxisome proliferator-activated receptor alpha interacting protein”. J. Biol. Chem.274 (22), 15901–7. o. DOI:10.1074/jbc.274.22.15901. PMID10336495.
Kodera Y, Takeyama K, Murayama A, Suzawa M, Masuhiro Y, Kato S (2000. október 1.). „Ligand type-specific interactions of peroxisome proliferator-activated receptor gamma with transcriptional coactivators”. J. Biol. Chem.275 (43), 33201–4. o. DOI:10.1074/jbc.C000517200. PMID10944516.
Kiernan R, Brès V, Ng RW, Coudart MP, El Messaoudi S, Sardet C, Jin DY, Emiliani S, Benkirane M (2003. január 1.). „Post-activation turn-off of NF-kappa B-dependent transcription is regulated by acetylation of p65”. J. Biol. Chem.278 (4), 2758–66. o. DOI:10.1074/jbc.M209572200. PMID12419806.
Gerritsen ME, Williams AJ, Neish AS, Moore S, Shi Y, Collins T (1997. április 1.). „CREB-binding protein/p300 are transcriptional coactivators of p65”. Proc. Natl. Acad. Sci. U.S.A.94 (7), 2927–32. o. DOI:10.1073/pnas.94.7.2927. PMID9096323. PMC20299.
Pearson KL, Hunter T, Janknecht R (1999. december 1.). „Activation of Smad1-mediated transcription by p300/CBP”. Biochim. Biophys. Acta1489 (2–3), 354–64. o. DOI:10.1016/S0167-4781(99)00166-9. PMID10673036.
Nakashima K, Yanagisawa M, Arakawa H, Kimura N, Hisatsune T, Kawabata M, Miyazono K, Taga T (1999. április 1.). „Synergistic signaling in fetal brain by STAT3-Smad1 complex bridged by p300”. Science284 (5413), 479–82. o. DOI:10.1126/science.284.5413.479. PMID10205054.
Pessah M, Prunier C, Marais J, Ferrand N, Mazars A, Lallemand F, Gauthier JM, Atfi A (2001. május 1.). „c-Jun interacts with the corepressor TG-interacting factor (TGIF) to suppress Smad2 transcriptional activity”. Proc. Natl. Acad. Sci. U.S.A.98 (11), 6198–203. o. DOI:10.1073/pnas.101579798. PMID11371641. PMC33445.
Grönroos E, Hellman U, Heldin CH, Ericsson J (2002. szeptember 1.). „Control of Smad7 stability by competition between acetylation and ubiquitination”. Mol. Cell10 (3), 483–93. o. DOI:10.1016/s1097-2765(02)00639-1. PMID12408818.
Kim RH, Wang D, Tsang M, Martin J, Huff C, de Caestecker MP, Parks WT, Meng X, Lechleider RJ, Wang T, Roberts AB (2000. július 1.). „A novel smad nuclear interacting protein, SNIP1, suppresses p300-dependent TGF-beta signal transduction”. Genes Dev.14 (13), 1605–16. o. DOI:10.1101/gad.14.13.1605. PMID10887155. PMC316742.
Eid JE, Kung AL, Scully R, Livingston DM (2000. szeptember 1.). „p300 interacts with the nuclear proto-oncoprotein SYT as part of the active control of cell adhesion”. Cell102 (6), 839–48. o. DOI:10.1016/s0092-8674(00)00072-6. PMID11030627.
McDonald C, Reich NC (1999. július 1.). „Cooperation of the transcriptional coactivators CBP and p300 with Stat6”. J. Interferon Cytokine Res.19 (7), 711–22. o. DOI:10.1089/107999099313550. PMID10454341.
Huang S, Qiu Y, Stein RW, Brandt SJ (1999. szeptember 1.). „p300 functions as a transcriptional coactivator for the TAL1/SCL oncoprotein”. Oncogene18 (35), 4958–67. o. DOI:10.1038/sj.onc.1202889. PMID10490830.
Bradney C, Hjelmeland M, Komatsu Y, Yoshida M, Yao TP, Zhuang Y (2003. január 1.). „Regulation of E2A activities by histone acetyltransferases in B lymphocyte development”. J. Biol. Chem.278 (4), 2370–6. o. DOI:10.1074/jbc.M211464200. PMID12435739.
Misra P, Qi C, Yu S, Shah SH, Cao WQ, Rao MS, Thimmapaya B, Zhu Y, Reddy JK (2002. május 1.). „Interaction of PIMT with transcriptional coactivators CBP, p300, and PBP differential role in transcriptional regulation”. J. Biol. Chem.277 (22), 20011–9. o. DOI:10.1074/jbc.M201739200. PMID11912212.
Gizard F, Lavallée B, DeWitte F, Hum DW (2001. szeptember 1.). „A novel zinc finger protein TReP-132 interacts with CBP/p300 to regulate human CYP11A1 gene expression”. J. Biol. Chem.276 (36), 33881–92. o. DOI:10.1074/jbc.M100113200. PMID11349124.
Hamamori Y, Sartorelli V, Ogryzko V, Puri PL, Wu HY, Wang JY, Nakatani Y, Kedes L (1999. február 1.). „Regulation of histone acetyltransferases p300 and PCAF by the bHLH protein twist and adenoviral oncoprotein E1A”. Cell96 (3), 405–13. o. DOI:10.1016/S0092-8674(00)80553-X. PMID10025406.
Lee JS, Galvin KM, See RH, Eckner R, Livingston D, Moran E, Shi Y (1995. május 1.). „Relief of YY1 transcriptional repression by adenovirus E1A is mediated by E1A-associated protein p300”. Genes Dev.9 (10), 1188–98. o. DOI:10.1101/gad.9.10.1188. PMID7758944.
Silverman ES, Du J, Williams AJ, Wadgaonkar R, Drazen JM, Collins T (1998. november 1.). „cAMP-response-element-binding-protein-binding protein (CBP) and p300 are transcriptional co-activators of early growth response factor-1 (Egr-1)”. Biochem. J.336 (1), 183–9. o. DOI:10.1042/bj3360183. PMID9806899. PMC1219856.
ncbi.nlm.nih.gov
Ntranos A, Casaccia P (2016. június 1.). „Bromodomains: Translating the words of lysine acetylation into myelin injury and repair”. Neuroscience Letters625, 4–10. o. DOI:10.1016/j.neulet.2015.10.015. PMID26472704. PMC4841751.
Teufel DP, Freund SM, Bycroft M, Fersht AR (2007. április 1.). „Four domains of p300 each bind tightly to a sequence spanning both transactivation subdomains of p53”. PNAS104 (17), 7009–7014. o. DOI:10.1073/pnas.0702010104. PMID17438265. PMC1855428.; Piskacek S, Gregor M, Nemethova M, Grabner M, Kovarik P, Piskacek M (2007. június 1.). „Nine-amino-acid transactivation domain: establishment and prediction utilities”. Genomics89 (6), 756–68. o. DOI:10.1016/j.ygeno.2007.02.003. PMID17467953.
Roelfsema JH, White SJ, Ariyürek Y, Bartholdi D, Niedrist D, Papadia F, Bacino CA, den Dunnen JT, van Ommen G-JB, Breuning MH, Hennekam RC, Peters DJM (2005. február 10.). „Genetic Heterogeneity in Rubinstein-Taybi Syndrome: Mutations in Both the CBP and EP300 Genes Cause Disease”. Am J Hum Genet76 (4), 572–580. o. DOI:10.1086/429130. PMID15706485. PMC1199295. (Hozzáférés: 2023. december 13.)
Liguori G, Cantile M, Collina F, Marra L, de Chiara A, Franco R, Caraglia M, Botti G, D'Andrea M, Nicoletti GF (2015. április 27.). „Atypical amplification of chromosome region 22q12 in melanoma: A case report”. DOI:10.1242/dmm.049078. PMID26171028. PMC4487132. (Hozzáférés: 2023. december 13.)
Bordonaro M, Lazarova DL (2015. július 21.). „CREB-binding protein, p300, butyrate, and Wnt signaling in colorectal cancer”. World J Gastroenterol21 (27), 8238–8248. o. DOI:10.3748/wjg.v21.i27.8238. PMID26217075. PMC4507093.
Zeng Q, Wang K, Zhao Y, Ma Q, Chen Z, Huang W (2023. február 22.). „Effects of the Acetyltransferase p300 on Tumour Regulation from the Novel Perspective of Posttranslational Protein Modification”. Biomolecules23 (24), 4225–4231. o. DOI:10.3390/biom13030417. PMID36979352. PMC10046601.
Zhong J, Ding L, Bohrer LR, Pan Y, Liu P, Zhang J, Sebo TJ, Karnes RJ, Tindall DJ, van Deursen J, Huang H (2014. január 30.). „P300 acetyltransferase regulates androgen receptor degradation and PTEN-deficient prostate tumorigenesis”. Cancer Res74 (6), 1870–1880. o. DOI:10.1158/0008-5472.CAN-13-2485. PMID24480624. PMC3971883.
Pao GM, Janknecht R, Ruffner H, Hunter T, Verma IM (2000. február 1.). „CBP/p300 interact with and function as transcriptional coactivators of BRCA1”. Proc. Natl. Acad. Sci. U.S.A.97 (3), 1020–5. o. DOI:10.1073/pnas.97.3.1020. PMID10655477. PMC15508.
Bhattacharya S, Michels CL, Leung MK, Arany ZP, Kung AL, Livingston DM (1999. január 1.). „Functional role of p35srj, a novel p300/CBP binding protein, during transactivation by HIF-1”. Genes Dev.13 (1), 64–75. o. DOI:10.1101/gad.13.1.64. PMID9887100. PMC316375.
Li QJ, Yang SH, Maeda Y, Sladek FM, Sharrocks AD, Martins-Green M (2003. január 1.). „MAP kinase phosphorylation-dependent activation of Elk-1 leads to activation of the co-activator p300”. EMBO J.22 (2), 281–91. o. DOI:10.1093/emboj/cdg028. PMID12514134. PMC140103.
Kang YK, Guermah M, Yuan CX, Roeder RG (2002. március 1.). „The TRAP/Mediator coactivator complex interacts directly with estrogen receptors alpha and beta through the TRAP220 subunit and directly enhances estrogen receptor function in vitro”. Proc. Natl. Acad. Sci. U.S.A.99 (5), 2642–7. o. DOI:10.1073/pnas.261715899. PMID11867769. PMC122401.
Freedman SJ, Sun ZY, Poy F, Kung AL, Livingston DM, Wagner G, Eck MJ (2002. április 1.). „Structural basis for recruitment of CBP/p300 by hypoxia-inducible factor-1 alpha”. Proc. Natl. Acad. Sci. U.S.A.99 (8), 5367–72. o. DOI:10.1073/pnas.082117899. PMID11959990. PMC122775.
Fryer CJ, Lamar E, Turbachova I, Kintner C, Jones KA (2002. június 1.). „Mastermind mediates chromatin-specific transcription and turnover of the Notch enhancer complex”. Genes Dev.16 (11), 1397–411. o. DOI:10.1101/gad.991602. PMID12050117. PMC186317.
Lau P, Bailey P, Dowhan DH, Muscat GE (1999. január 1.). „Exogenous expression of a dominant negative RORalpha1 vector in muscle cells impairs differentiation: RORalpha1 directly interacts with p300 and myoD”. Nucleic Acids Res.27 (2), 411–20. o. DOI:10.1093/nar/27.2.411. PMID9862959. PMC148194.
De Luca A, Severino A, De Paolis P, Cottone G, De Luca L, De Falco M, Porcellini A, Volpe M, Condorelli G (2003. február 1.). „p300/cAMP-response-element-binding-protein ('CREB')-binding protein (CBP) modulates co-operation between myocyte enhancer factor 2A (MEF2A) and thyroid hormone receptor-retinoid X receptor”. Biochem. J.369 (Pt 3), 477–84. o. DOI:10.1042/BJ20020057. PMID12371907. PMC1223100.
Ko L, Cardona GR, Chin WW (2000. május 1.). „Thyroid hormone receptor-binding protein, an LXXLL motif-containing protein, functions as a general coactivator”. Proc. Natl. Acad. Sci. U.S.A.97 (11), 6212–7. o. DOI:10.1073/pnas.97.11.6212. PMID10823961. PMC18584.
García-Rodríguez C, Rao A (1998. június 1.). „Nuclear factor of activated T cells (NFAT)-dependent transactivation regulated by the coactivators p300/CREB-binding protein (CBP)”. J. Exp. Med.187 (12), 2031–6. o. DOI:10.1084/jem.187.12.2031. PMID9625762. PMC2212364.
Gerritsen ME, Williams AJ, Neish AS, Moore S, Shi Y, Collins T (1997. április 1.). „CREB-binding protein/p300 are transcriptional coactivators of p65”. Proc. Natl. Acad. Sci. U.S.A.94 (7), 2927–32. o. DOI:10.1073/pnas.94.7.2927. PMID9096323. PMC20299.
Pessah M, Prunier C, Marais J, Ferrand N, Mazars A, Lallemand F, Gauthier JM, Atfi A (2001. május 1.). „c-Jun interacts with the corepressor TG-interacting factor (TGIF) to suppress Smad2 transcriptional activity”. Proc. Natl. Acad. Sci. U.S.A.98 (11), 6198–203. o. DOI:10.1073/pnas.101579798. PMID11371641. PMC33445.
Kim RH, Wang D, Tsang M, Martin J, Huff C, de Caestecker MP, Parks WT, Meng X, Lechleider RJ, Wang T, Roberts AB (2000. július 1.). „A novel smad nuclear interacting protein, SNIP1, suppresses p300-dependent TGF-beta signal transduction”. Genes Dev.14 (13), 1605–16. o. DOI:10.1101/gad.14.13.1605. PMID10887155. PMC316742.
Silverman ES, Du J, Williams AJ, Wadgaonkar R, Drazen JM, Collins T (1998. november 1.). „cAMP-response-element-binding-protein-binding protein (CBP) and p300 are transcriptional co-activators of early growth response factor-1 (Egr-1)”. Biochem. J.336 (1), 183–9. o. DOI:10.1042/bj3360183. PMID9806899. PMC1219856.
